The Hypercalcemia of Cancer Clinical Implications and Pathogenic Mechanisms
HYPERCALCEMIA is one of the most common metabolic complications of cancer. It has fascinated clinicians since it was first recognized 60 years ago by Zondek et al. 1 It is now being recognized more commonly, as is primary hyperparathyroidism, because of the advent of routine measurement of the serum...
Saved in:
Published in | The New England journal of medicine Vol. 310; no. 26; pp. 1718 - 1727 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Boston, MA
Massachusetts Medical Society
28.06.1984
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | HYPERCALCEMIA is one of the most common metabolic complications of cancer. It has fascinated clinicians since it was first recognized 60 years ago by Zondek et al.
1
It is now being recognized more commonly, as is primary hyperparathyroidism, because of the advent of routine measurement of the serum calcium level.
2
,
3
The estimated incidence of the hypercalcemia of cancer is 150 new cases per million persons per year.
2
,
3
This compares with an annual incidence of approximately 250 new cases of primary hyperparathyroidism per year.
2
,
3
However, the relative frequency of cancer as a cause of hypercalcemia is even greater in hospital populations, . . . |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ISSN: | 0028-4793 1533-4406 |
DOI: | 10.1056/NEJM198406283102607 |